MIR1264: A Potential Drug Target and Biomarker for Obesity (G100302251)

MIR1264: A Potential Drug Target and Biomarker for Obesity

Obesity is a significant public health issue that affects millions of people worldwide, leading to various health problems such as cardiovascular diseases, diabetes, and certain cancers. The identification of potential drug targets and biomarkers for obesity could lead to the development of more effective treatments. MIR1264 is a gene that has been identified as a potential drug target and biomarker for obesity. In this article, we will discuss the potential implications of MIR1264 as a drug target and biomarker for obesity.

MIR1264: What is MIR1264?

MIR1264 is a gene that encodes a protein known as MIR1264. The MIR1264 protein is a member of the superfamily of water-splitting proteins, which are involved in the production of water during photosynthesis. MIR1264 is expressed in various tissues and cells, including adipocytes, which are the fatty tissues that store energy in the form of fat.

MIR1264: Potential Drug Target

Obesity is associated with an increased risk of various diseases, including cardiovascular diseases, diabetes, and certain cancers. MIR1264 has been identified as a potential drug target for obesity because of its involvement in energy metabolism. MIR1264 is involved in the production of ATP, which is the energy currency of the cell. It has been shown that MIR1264 is involved in the production of ATP, which is essential for various cellular processes, including protein synthesis, DNA replication, and cell growth.

MIR1264 has also been shown to be involved in the regulation of lipid metabolism, which is the process by which the body produces and absorbs fat. MIR1264 has been shown to play a role in the production of fatty acids, which are essential for the maintenance of brain function, eye health, and immune system function.

MIR1264: Potential Biomarker

MIR1264 has also been identified as a potential biomarker for obesity. Obesity is associated with an increased risk of various diseases, including cardiovascular diseases, diabetes, and certain cancers. The identification of biomarkers for obesity could lead to the development of more effective treatments. MIR1264 is a potential biomarker for obesity because of its involvement in energy metabolism and lipid metabolism.

MIR1264 has been shown to be involved in the production of ATP, which is the energy currency of the cell. It has also been shown to play a role in the regulation of lipid metabolism, which is the process by which the body produces and absorbs fat. MIR1264 has been shown to be involved in the production of fatty acids, which are essential for the maintenance of brain function, eye health, and immune system function.

MIR1264: MIR1264 as a Potential Drug Target

The identification of MIR1264 as a potential drug target for obesity is an exciting development in the field of obesity research. MIR1264 is involved in energy metabolism and lipid metabolism, which are crucial processes for the maintenance of weight and body composition. The development of drugs that target MIR1264 could lead to the development of more effective treatments for obesity.

MIR1264 has also been shown to be involved in the regulation of body weight and appetite. MIR1264 has been shown to play a role in the production of

Protein Name: MicroRNA 1264

The "MIR1264 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1264 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B